Detalhe da pesquisa
1.
High percentage of bone marrow CD8+ tissue-resident-like memory T cells predicts inferior survival in patients with acute myeloid leukemia.
Blood Sci;
6(3): e00194, 2024 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-38854481
2.
A20 Promoter rs5029924 Concomitant with rs2230926 and rs5029937 May Be a Prognostic Predictor for Joint Deformity or Refractory Rheumatoid Arthritis.
Int J Gen Med;
17: 1707-1712, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38706751
3.
Long-Term Follow-Up of Patients Undergoing Thalidomide Therapy for Transfusion-Dependent ß-Thalassaemia: A Single-Center Experience.
Int J Gen Med;
17: 1729-1738, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711824
4.
BET Inhibitor JQ1 Selectively Reduce Tregs by Upregulating STAT3 and Suppressing PD-1 Expression in Patients with Multiple Myeloma.
Adv Biol (Weinh);
: e2300640, 2024 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38797917
5.
Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML.
Front Immunol;
15: 1321126, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711501
6.
BCL11B promotes T-cell acute lymphoblastic leukaemia cell survival via the XRCC5/C11ORF21 axis.
Clin Transl Med;
14(2): e1580, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317587
7.
PD-L1 expression guidance on sintilimab versus pembrolizumab with or without platinum-doublet chemotherapy in untreated patients with advanced non-small cell lung cancer (CTONG1901): A phase 2, randomized, controlled trial.
Sci Bull (Beijing);
69(4): 535-543, 2024 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38185589
8.
Inhibition of NRF2 enhances the acute myeloid leukemia cell death induced by venetoclax via the ferroptosis pathway.
Cell Death Discov;
10(1): 35, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238299
9.
Immune checkpoint expression patterns on T cell subsets in light-chain amyloidosis: VISTA, PD-1, and TIGIT as potential therapeutic targets.
Blood Sci;
6(1): e00181, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38226018
10.
CD69 is a Promising Immunotherapy and Prognosis Prediction Target in Cancer.
Immunotargets Ther;
13: 1-14, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38223406
11.
T-cell lymphoma patient harboring BCL11B mutations had favorable overall survival.
Asia Pac J Clin Oncol;
20(1): 81-86, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37635422
12.
Single-cell RNA sequencing gene signatures for classifying and scoring exhausted CD8+ T cells in B-cell acute lymphoblastic leukaemia.
Cell Prolif;
57(3): e13583, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38030593
13.
BCL11B Mutations Are Associated with Higher CD8+ T-Cell Percentage and Favorable Clinical Outcomes in Patients with T-Cell Acute Lymphoblastic Leukemia.
Clin Med Insights Oncol;
17: 11795549231216427, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-38058602
14.
Higher PD-1/Tim-3 expression on IFN-γ+ T cells is associated with poor prognosis in patients with acute myeloid leukemia.
Cancer Biol Ther;
24(1): 2278229, 2023 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-37962843
15.
CASP1 is a target for combination therapy in pancreatic cancer.
Eur J Pharmacol;
961: 176175, 2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37949157
16.
Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
J Hematol Oncol;
16(1): 101, 2023 09 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37670328
17.
Higher 13-Gene-Estimated TMB Detected from Plasma ctDNA is Associated with Worse Outcome for T-Cell Lymphoma Patients.
Adv Biol (Weinh);
7(12): e2300042, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37658484
18.
BCL11B and the NuRD complex cooperatively guard T-cell fate and inhibit OPA1-mediated mitochondrial fusion in T cells.
EMBO J;
42(21): e113448, 2023 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37737560
19.
Correction: Targeting LAG-3, TIM-3, and TIGIT for cancer immunotherapy.
J Hematol Oncol;
16(1): 105, 2023 Sep 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-37773132
20.
Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting.
Exp Hematol Oncol;
12(1): 62, 2023 Jul 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-37468979